Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial.
Erin KubilaySteven TrawleyGlenn M WardSpiros FourlanosCharlotte A GrillsMelissa H LeeRichard J MacIsaacDavid Norman O'NealNiamh A O'ReganVijaya SundararajanSara VogrinPeter G ColmanSybil A McAuleyPublished in: Diabetic medicine : a journal of the British Diabetic Association (2022)
The lived experience of older adults without frailty or major cognitive impairment using first-generation closed-loop therapy was mainly positive, concordant with glycaemic benefits found in the trial. Older adults' lived experience using automated insulin delivery beyond trial environments requires exploration; moreover, usability needs of older adults should be considered during future device development.
Keyphrases
- type diabetes
- physical activity
- study protocol
- cognitive impairment
- machine learning
- clinical trial
- deep learning
- phase iii
- high throughput
- randomized controlled trial
- glycemic control
- healthcare
- phase ii
- open label
- stem cells
- electronic health record
- mesenchymal stem cells
- health information
- bone marrow
- social media
- current status
- double blind